Trademark: 79282641
Word

Status
Registered
Status Code
700
Status Date
Tuesday, September 22, 2020
Serial Number
79282641
Registration Number
6155900
Registration Date
Tuesday, September 22, 2020
Mark Type
2000
Filing Date
Monday, February 10, 2020
Published for Opposition
Tuesday, July 7, 2020

Trademark Owner History
NOVARTIS AG - Original Registrant

Classifications
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
The color(s) orange, blue and yellow is/are claimed as a feature of the mark.
The mark consists of a curved orange and blue band below and to the left of a curved blue and yellow band pointing left.

Trademark Events
Feb 14, 2021
Final Decision Transaction Processed By Ib
Jan 15, 2021
Generic Madrid Transaction Sent To Ib
Jan 15, 2021
Generic Madrid Transaction Created
Dec 22, 2020
Final Disposition Notice Created, To Be Sent To Ib
Sep 22, 2020
Registered-Principal Register
Jul 7, 2020
Official Gazette Publication Confirmation E-Mailed
Jul 7, 2020
Published For Opposition
Jun 17, 2020
Notification Of Notice Of Publication E-Mailed
Jun 1, 2020
Approved For Pub - Principal Register
May 29, 2020
Refusal Processed By Ib
May 25, 2020
Teas/Email Correspondence Entered
May 24, 2020
Correspondence Received In Law Office
May 24, 2020
Teas Response To Office Action Received
May 19, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
May 19, 2020
Teas Change Of Correspondence Received
May 19, 2020
Teas Change Of Domestic Representatives Address
May 19, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
May 19, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 19, 2020
Teas Change Of Owner Address Received
May 13, 2020
Non-Final Action Mailed - Refusal Sent To Ib
May 13, 2020
Refusal Processed By Mpu
Apr 29, 2020
Non-Final Action (Ib Refusal) Prepared For Review
Apr 28, 2020
Non-Final Action Written
Apr 28, 2020
Non-Final Action Written
Apr 28, 2020
Non-Final Action Written
Apr 28, 2020
Non-Final Action Written
Apr 28, 2020
Non-Final Action Written
Apr 24, 2020
Assigned To Examiner
Apr 24, 2020
Application Filing Receipt Mailed
Apr 20, 2020
New Application Office Supplied Data Entered In Tram
Apr 14, 2020
Limitation From Original Application Entered
Apr 9, 2020
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24